155 related articles for article (PubMed ID: 34930551)
1. Endogenous Trichosporon Asahii Retinitis.
Parrozzani R; Marchione G; Midena G
Ophthalmology; 2022 Jan; 129(1):66. PubMed ID: 34930551
[No Abstract] [Full Text] [Related]
2. Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia.
Cardenas-de la Garza JA; Ancer-Arellano J; Cuellar-Barboza A; Saenz-Ibarra B; Ocampo-Garza SS; Barboza-Quintana O; Gallardo-Rocha A; Vera-Cabrera L; Ocampo-Candiani J; Welsh O
J Dermatol; 2019 Apr; 46(4):e128-e129. PubMed ID: 30295013
[No Abstract] [Full Text] [Related]
3. Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
Nguyen JK; Schlichte MJ; Schady D; Pourciau CY
Pediatr Dermatol; 2018 Jan; 35(1):e86-e87. PubMed ID: 29266471
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
[TBL] [Abstract][Full Text] [Related]
5. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Ramírez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
6. Trichosporonosis in Pediatric Patients With a Hematologic Disorder.
Foster CE; Edwards MS; Brackett J; Schady DA; Healy CM; Baker CJ
J Pediatric Infect Dis Soc; 2018 Aug; 7(3):199-204. PubMed ID: 28510690
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
Hosokawa K; Yamazaki H; Mochizuki K; Ohata K; Ishiyama K; Hayashi T; Kondo Y; Sugimori N; Okumura H; Takami A; Nakao S
Transpl Infect Dis; 2012 Apr; 14(2):184-7. PubMed ID: 22093149
[TBL] [Abstract][Full Text] [Related]
9. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Antachopoulos C; Papakonstantinou E; Dotis J; Bibashi E; Tamiolaki M; Koliouskas D; Roilides E
J Pediatr Hematol Oncol; 2005 May; 27(5):283-5. PubMed ID: 15891566
[TBL] [Abstract][Full Text] [Related]
10. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
11. Bilateral Asymptomatic Cryptococcal Retinitis without Choroiditis or Vitritis.
Johnson WJ; Blice JP; Lee KK
Ophthalmology; 2018 Apr; 125(4):528. PubMed ID: 29566868
[No Abstract] [Full Text] [Related]
12. Postoperative fungal endophthalmitis caused by Trichosporon asahii treated with voriconazole.
Gonul S; Gedik S; Ozturk BT; Bakbak B; Koktekir BE; Okudan S; Dagı HT
Arq Bras Oftalmol; 2015; 78(4):252-4. PubMed ID: 26375343
[TBL] [Abstract][Full Text] [Related]
13. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
14.
Mohanty A; Meena S; Nath UK; Bakliwal A; Kaistha N; Gupta P
Indian J Pathol Microbiol; 2021; 64(3):619-621. PubMed ID: 34341294
[No Abstract] [Full Text] [Related]
15. Endogenous Scedosporium apiospermum endophthalmitis.
Jain A; Egbert P; McCulley TJ; Blumenkranz MS; Moshfeghi DM
Arch Ophthalmol; 2007 Sep; 125(9):1286-9. PubMed ID: 17846376
[No Abstract] [Full Text] [Related]
16. Trichosporon asahii, sepsis, and secondary hemophagocytic lymphohistiocytosis in children with hematologic malignancy.
Karapinar DY; Karadaş N; Yazici P; Polat SH; Karapinar B
Pediatr Hematol Oncol; 2014 Apr; 31(3):282-4. PubMed ID: 24383917
[TBL] [Abstract][Full Text] [Related]
17. Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview.
Kruschewsky WLL; Massaroni-Peçanha P; Maifrede SB; Leite MS; Pôssa TAL; Alberto-Lei F; Cayô R; Peçanha PM; Gonçalves SS
Braz J Microbiol; 2022 Sep; 53(3):1221-1229. PubMed ID: 35378689
[TBL] [Abstract][Full Text] [Related]
18. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the characteristics of patients with invasive infections and noninvasive infections caused by Trichosporon asahii.
Kim J; Kim MJ; Chong YP; Kim SH; Choi SH; Lee SO; Woo JH; Kim YS; Jung J
Med Mycol; 2021 Mar; 59(3):296-300. PubMed ID: 32876327
[TBL] [Abstract][Full Text] [Related]
20. Trichosporon Asahii fungaemia in an immunocompetent polytrauma patient who received multiple antibiotics.
Ding CH; Khaithir TMN; Wahab AA; Faiz MA; Saarah WR
Malays J Pathol; 2020 Aug; 42(2):293-296. PubMed ID: 32860385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
